The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Cyanoacrylate pulmonary embolism
Publications
Pietrasik A, G?secka A, Chojecka D, Pytlos J, Rymuza B, G?ówczy?ska R, Banaszkiewicz M, Darocha S, Kurzyna M
Iatrogenic pulmonary embolism with cyanoacrylate - to remove, or to leave?
Kardiologia polska 2021;79;706-707 — 2021 — 706-707
Frassei JDS, Franco CS, Brambilla VR, Loureiro BMC, Kiebert CDS, Fonseca EKUN, Ando SM, Sawamura MVY
Cyanoacrylate pulmonary embolism after endoscopic sclerotherapy of gastric varices.
Einstein (Sao Paulo, Brazil) 2021;19;eAI5778 — 2021 — eAI5778